Mette Soendergaard

I'm the co-founder of Cell Origins, a biotech company specializing in phage display and peptide discovery. Trained at the University of Missouri, where George Smith pioneered phage display, I have built my career around advancing peptide- and antibody-based platforms for research and therapeutic development. My work bridges advanced display technologies with applications in oncology, with a focus on fostering partnerships across diverse scientific disciplines.